{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:03:30Z","timestamp":1793729010335,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.blre.2024.101253","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:13:14Z","timestamp":1734023594000},"page":"101253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Impact of transcranial Doppler screening on stroke prevention in children and adolescents with sickle cell disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"69","author":[{"given":"Danielle","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bagnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoluwa","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Nevi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liga","family":"Bennetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Odame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2024.101253_bb0005","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2024.101253_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/archdischild-2021-323633","article-title":"Sickle cell disease in children: an update of the evidence in low- and middle-income settings","volume":"108","author":"Odame","year":"2023","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.blre.2024.101253_bb0015","series-title":"Sickle-cell disease in the African region: current situation and the way forward","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.blre.2024.101253_bb0020","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission","volume":"10","author":"Piel","year":"2023","journal-title":"The Lancet Haematol"},{"key":"10.1016\/j.blre.2024.101253_bb0025","unstructured":"American Heart Association Sickle Cell Disease and Pediatric Stroke Risk. https:\/\/www.stroke.org\/en\/about-stroke\/stroke-in-children\/sickle-cell-disease (accessed 30th August 2024)."},{"key":"10.1016\/j.blre.2024.101253_bb0030","series-title":"Sickle Cell Disease and Stroke","author":"Nationwide Children\u2019s Hospital","year":"2022"},{"key":"10.1016\/j.blre.2024.101253_bb0035","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2024.101253_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2013.05.006","article-title":"Stroke in sickle cell anemia patients: A need for multidisciplinary approaches","volume":"229","author":"Menaa","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2024.101253_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0032-1331812","article-title":"Transcranial doppler ultrasound: technique and application","volume":"32","author":"Farzaneh","year":"2013","journal-title":"Semin Neurol"},{"key":"10.1016\/j.blre.2024.101253_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2024.101253_bb0055","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2024.101253_bb0060","first-page":"n71","article-title":"The PRISMA statement: an updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101253_bb0065","series-title":"WHO handbook for guideline development","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.blre.2024.101253_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.blre.2024.101253_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101253_bb0100","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","author":"Higgins","year":"2023"},{"key":"10.1016\/j.blre.2024.101253_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.blre.2024.101253_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101253_bb0085","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2024.101253_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.blre.2024.101253_bb0095","unstructured":"R Core Team R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available at: https:\/\/www.gbif.org\/tool\/81287\/r-a-language-and-environment-for-statistical-computing R: A language and environment for statistical computing. (accessed 28th August 2024)t."},{"key":"10.1016\/j.blre.2024.101253_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.blre.2024.101253_bb0160","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","volume":"7","author":"Estcourt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2024.101253_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/1747493017706189","article-title":"Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review","volume":"12","author":"Mazzucco","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.blre.2024.101253_bb0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2024.101253_bb0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.blre.2024.101253_bb0125","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.0b013e3181a110da","article-title":"Utilization of TCD screening for primary stroke prevention in children with sickle cell disease","volume":"72","author":"Armstrong-Wells","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2024.101253_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00247-005-1419-5","article-title":"Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler","volume":"35","author":"Bernaudin","year":"2005","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.blre.2024.101253_bb0135","doi-asserted-by":"crossref","unstructured":"Bernaudin F., Verlhac S., Arnaud C., Kamdem A., Chevret S., Hau I., et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011;117:1130\u20131140. quiz 1436 doi: 10.1182\/blood-2010-06-293514.","DOI":"10.1182\/blood-2010-06-293514"},{"key":"10.1016\/j.blre.2024.101253_bb0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2010.03.007","article-title":"Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease","volume":"157","author":"Enninful-Eghan","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2024.101253_bb0145","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/ajh.25635","article-title":"Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era","volume":"94","author":"Kwiatkowski","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2024.101253_bb0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.21430","article-title":"Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia","volume":"50","author":"McCarville","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2024.101253_bb0155","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.htct.2021.05.001","article-title":"Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke","volume":"44","author":"Sabarense","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.blre.2024.101253_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","article-title":"Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study","volume":"15","author":"Adams","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.blre.2024.101253_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.htct.2021.09.013","article-title":"Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associa\u00e7\u00e3o M\u00e9dica Brasileira - 2021","volume":"44","author":"Loggetto","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.blre.2024.101253_bb0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12955-021-01868-9","article-title":"Stroke risk and its association with quality of life: a cross-sectional study among Chinese urban adults","volume":"19","author":"Yao","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.blre.2024.101253_bb0200","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/STROKEAHA.115.011622","article-title":"Outcome in childhood stroke","volume":"47","author":"Greenham","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2024.101253_bb0205","first-page":"10","article-title":"Epidemiology of stroke in sickle cell disease","author":"Kirkham","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2024.101253_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01956144","article-title":"Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease","volume":"152","author":"de Montalembert","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.blre.2024.101253_bb0215","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2024.101253_bb0220","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"}],"updated-by":[{"DOI":"10.1016\/j.blre.2025.101258","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X24000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:14:55Z","timestamp":1740579295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X24000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0268960X24000869"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2024.101253","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of transcranial Doppler screening on stroke prevention in children and adolescents with sickle cell disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2024.101253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101253"}}